Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 385 of the 388 references it cites were found in a registry or an index.

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Bruni, Daniela, Angell, Helen K., Galon, Jérôme · 2020 · Nature reviews. Cancer

Abstract

The international American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) tumour-node-metastasis (TNM) staging system provides the current guidelines for the classification of cancer. However, among patients within the same stage, the clinical outcome can be very different. More recently, a novel definition of cancer has emerged, implicating at all stages a complex and dynamic interaction between tumour cells and the immune system. This has enabled the definition of the immune contexture, representing the pre-existing immune parameters associated with patient survival. Even so, the role of distinct immune cell types in modulating cancer progression is increasingly emerging. An immune-based assay named the 'Immunoscore' was defined to quantify the in situ T cell infiltrate and was demonstrated to be superior to the AJCC/UICC TNM classification for patients with colorectal cancer. This Review provides a broad overview of the main immune parameters positively or negatively shaping cancer development, including the Immunoscore, and their prognostic and predictive value. The importance of the immune system in cancer control is demonstrated by the requirement for a pre-existing intratumour adaptive immune response for effective immunotherapies, such as checkpoint inhibitors. Finally, we discuss how the combination of multiple immune parameters, rather than individual ones, might increase prognostic and/or predictive power.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41568-020-0285-7

Cites

385 of 385 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 388 references

Cited by

See all 1,586

Metadata

Authors
Bruni, D., Angell, H. K., & Galon, J.
Affiliations
  • Inserm (FR)
  • AstraZeneca (United Kingdom) (GB)
Corresponding author
Galon, Jérôme
Venue
Nature reviews. Cancer
Published
2020-08-04
Volume
20
Issue
11
Pages
662-680
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W3047106569
Cited by
1,586
References
388
Citations by year
2026: 154 · 2025: 242 · 2024: 324 · 2023: 352 · 2022: 302 · 2021: 202 · 2020: 10
FWCI
23.85
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
immune contexture, immune score, tumor immune microenvironment, T cell infiltration, colorectal cancer, TNM staging, cancer prognosis, predictive biomarkers, immunotherapy response, immune checkpoint inhibitors
MeSH terms
Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors, Humans, Immune System, Immunoassay, Neoplasm Staging, Neoplasms, Predictive Value of Tests, Prognosis, Severity of Illness Index, Biomarkers, Tumor, Colorectal Neoplasms, Survival Analysis, Treatment Outcome, Disease Progression, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. https://app.cochat.ai/papers/10.1038/s41568-020-0285-7
The paper
Bruni, D., Angell, H. K., & Galon, J. (2020). The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nature reviews. Cancer. https://doi.org/10.1038/s41568-020-0285-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.